0000899243-19-005280.txt : 20190228 0000899243-19-005280.hdr.sgml : 20190228 20190228173626 ACCESSION NUMBER: 0000899243-19-005280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190227 FILED AS OF DATE: 20190228 DATE AS OF CHANGE: 20190228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schor Chen CENTRAL INDEX KEY: 0001340875 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 19645233 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: resTORbio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-27 0 0001720580 resTORbio, Inc. TORC 0001340875 Schor Chen C/O RESTORBIO, INC. 500 BOYLSTON STREET, 12TH FLOOR BOSTON MA 02116 1 1 0 0 President and CEO Stock Option (Right to Buy) 8.53 2019-02-27 4 A 0 214000 0.00 A 2029-02-26 Common Stock 214000 214000 D 25% of the shares shall vest on February 27, 2020, with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Chen Schor 2019-02-28